期刊文献+

维生素D通过抗氧化应激减轻糖尿病肾病 被引量:4

Vitamin D alleviates diabetic nephropathy of rats by resisting oxidative stress
原文传递
导出
摘要 目的研究维生素D是否通过抑制氧化应激在糖尿病肾病(DN)中产生保护作用。方法应用链脲佐菌素(STZ)腹腔注射诱导糖尿病大鼠模型,经过两个月持续喂养诱导DN模型。将大鼠随机分为三组,糖尿病肾病骨化三醇干预组(DNR组)予骨化三醇0.2μg·kg^(-1)·d^(-1)灌胃,正常对照组(NC组)和DN组仅给予等容量花生油,均灌胃一个月。检测给药前后大鼠体重、随机血糖、血脂、血清丙二醛及总超氧化物歧化酶(T-SOD)、总抗氧化能力(T-AOC)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-PX)水平等。电镜观察大鼠肾脏超微结构改变,real-time PCR检测大鼠肾脏谷胱甘肽过氧化物酶1(GPX1)、超氧化物歧化酶1和2(SOD1、SOD2)mRNA表达水平。结果与NC组比较,DN组和DNR组大鼠体重降低,血糖、三酰甘油水平升高(P<0.05或P<0.01)。DN组肾重-体重比和尿微量白蛋白-肌酐比值(UA/Cr)明显高于NC组(P<0.01),DNR组肾重-体重比和UA/Cr均低于DN组(P<0.05或P<0.01)。DN组血清丙二醛水平高于NC组,T-SOD、T-AOC、CAT、GSH-PX活性及肾脏GPX1、SOD1、SOD2 mRNA水平均低于NC组(P<0.01),肾脏超微结构出现明显异常。DNR组血清丙二醛水平低于DN组,T-SOD、T-AOC、CAT、GSH-PX活性及肾脏GPX1、SOD1、SOD2 mRNA水平均高于DN组(P<0.05或P<0.01),肾脏超微结构异常明显改善。结论维生素D可能通过增加肾脏的抗氧化能力减轻DN大鼠的氧化应激,从而发挥其对DN的保护作用。 AIM To study whether vitamin D inhibits oxidative stress to protect diabetic nephropathy (DN). METHODS The diabetic rats were induced by intraperitoneal injection with streptozotocin. Then, the diabetic rats were fed with rodent chow about 2 months to induce DN. The rats were randomly divided into three groups. The intragastric administration with calcitriol 0.2 p·g·kg-1·d-1 was applied to DN rats in the calcitrioltreatment (DNR)group. The rats in the normal control (NC) group and DN group were only treated with equivalent arachisoil. After 1 month treatment, the body weight of rats, random blood glucose, the level of malondialdehyde (MDA), total superoxide dismutase (T- SOD), total antioxidant capacity (T- AOC), hydrogen peroxidase (CAT) and glutathion peroxidase (GSH-PX) of rats serum in each group were tested. The ultra-structure of rats kidneys was observed with electron microscope. The mRNA expression of glutathion peroxidase 1 (GPX1), superoxide dismutase 1 and 2 (SOD1, SOD2) of kidneys were detected by means of real-time PCR. RESULTS Compared with NC group, the body weight of rats was decreased in the group DN and DNR, but serum glucose and triglyceride were increased significantly (P 〈 0.05 or P 〈 0.01 ). The kidney weight to body weight ratio and UA/Cr in the group DN were more elevated than those of group NC and DNR (P 〈 0.05 or P 〈 0.01). Compared with group NC, the serum MDA in the group DN was higher and the activity of serum T-SOD, T-AOC, CAT, GSH-PX and the renal mRNA expression of GPX1, SOD2 and SOD1 were reduced (P 〈 0.01 ). In the meantime, the ultra-structure of rats kidneys showed obviously abnormal changes in the group DN. Compared with group DN, the MDA in the group DNR was reduced obviously, while the activity of serum T-SOD, T-AOC, CAT, GSH-PX and the renal mRNA expression of GPX1, SOD2 and SOD1 in group DNR were increased (P 〈 0.05 or P 〈 0.01). As a result, the renal ultra-structure improved predominantly. CONCLUSION Vitamin D can improve DN of rats significantly. This protective effect might be related to alleviate oxidative stress of rats by raising anti-oxidant ability of kidney.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2013年第9期721-726,共6页 Chinese Journal of New Drugs and Clinical Remedies
基金 常州市社科基金项目(CS20092021)
关键词 维生素D 骨化三醇 糖尿病肾病 大鼠 氧化应激 vitamin D caleitriol diabetic nephropathies rats oxidative stress
  • 相关文献

参考文献20

  • 1YANG W, LU J, WENG J, et aL Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362 (12): 1090-1101.
  • 2ZHANG Y, DEB DK, KONG J, et cal. Long-term therapeutic: effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with ATI receptor antagonist[J]. Am J Physiol Renal Physiol, 2009, 297(3): F791-F801.
  • 3PARVING HH, LEHNERT H, BROCHNER-MORTENSEN J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J]. N Engl J Med, 2001, 345(12): 870-878.
  • 4AGARWAL R. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD[J]. Clin J Am Soc Nephrol, 2009, 4 (9): 1523-1528.
  • 5ZHANG Z, YUAN W, SUN L, eta/. 1,25- Dihydroxyvitamin D3 targeting of NF-kappa B suppresses high glucose-induced MCP-1 expression in mesangial cells [J]. Kidney Int, 2007, 72 (2): 193-201.
  • 6FORBES JM, COUGHLAN MT, COOPER ME. Oxidative stress as a major culprit in kidney disease in diabetes [J]. Diabetes, 2008, 57(6) : 1446-1454.
  • 7MONTILLA P, BARCOS M, MUNOZ MC, et al. Red wine prevents brain oxidative stress and nephropathy in streptozotocin- induced diabetic rats[J]. J Biochem Mol Biol, 2005, 38(5): 539- 544.
  • 8RAZA H, PRABU SK, JOHN A, et al. Impaired mitochondrial respiratory functions and oxidative stress in streptozotocin- induced diabetic rats[J]. Int J Mol Sci, 2011, 12 (5): 3133- 3147.
  • 9CETINKALP S, DELEN Y, KARADEN1Z M, et al. The effect of lalpha, 25 (OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where type 1 diabetes is formed by streptozotocin[J]. J Diabetes Complications, 2009, 23 (6): 4(I 1-408.
  • 10SINGH DK, WINOCOUR P, FARRINGTON K. Oxidative stress in early diabetic nephropathy: fueling the fire [J]. Nat Rev Endocrinol, 2011, 7(3): 176-184.

二级参考文献20

  • 1Pittas AG,LauJ,HuFB,eta].The role of vitamin Dandcalcium in type 2 diabetes:a systematic review and meta-analysis.J Clin Endocrinol Metab,2007,92(6):2017-2029.
  • 2Martins D,Wolf M,Pan D,et al.Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States:data from the Third National Health and Nutrition Examination Survey.Arch Intern Med,2007,167 (11):1159-1165.
  • 3American Diabetes Association.Standards of medical care in diabetes-2008.Diabetes Care,2008,31 Suppl 1:S12-54.
  • 4Pittas AG,Harris SS,Stark PC,et al.The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.Diabetes Care,2007,30(4):980-986.
  • 5Forouhi NG,Luan J,Cooper A,et al.Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance:the Medical Research Council Ely Prospective Study 1990-2000.Diabetes,2008,57(10):2619-2625.
  • 6Gupta AK,Brashear MM,Johnson WD.Prediabetes and prehypertension in healthy adults are associated with low vitamin d levels.Diabetes Care,2011,34(3):658-660.
  • 7Del Gobbo LC,Song Y,Dannenbanm DA,et al.Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree.J Nutr,2011,141 (2):290-295.
  • 8Nikooyeh B,Neyestani TR,Farvid M,etal.Daily consumption of vitamin D-or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes:a randomized clinical trial.Am J Clin Nutr,2011,93(4):764-771.
  • 9Bizzarri C,Pitocco D,Napoli N,et al.No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes:the IMDIAB ⅩⅢ trial.Diabetes Care,2010,33 (9):1962-1963.
  • 10LI YC. Podocytes as target of vitamin D[J]. Curt Diabetes Rev, 2011, 7(1): 35-40.

共引文献15

同被引文献84

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部